Prøve GULL - Gratis
India's biopharma industry charts the road from biosimilars to innovation
Express Pharma
|November 2025
Express Pharma hosted the maiden Biopharma Leadership Conclave 2025 and brought together industry leaders to discuss how India can move from being the world's leading producer of generics and biosimilars to becoming a hub for innovative, affordable, and high-quality biologics and advanced therapies
-
Global health needs are changing fast.
New challenges such as complex diseases, rare conditions, and personalised treatments are reshaping how therapies are developed and delivered. Technology is also transforming discovery and manufacturing. This shift opens a new window of opportunity for biopharma in India.
To explore this potential, Express Pharma hosted the Biopharma Leadership Conclave 2025, under the theme, 'The future of biopharma: Made in India'.
Held at Hilton Garden Inn, Pune Hinjawadi, the conclave brought together industry leaders, entrepreneurs, researchers, innovators and ecosystem partners to discuss how India can move from being the world’s leading producer of generics and biosimilars to becoming a hub for innovative, affordable, and high-quality biologics and advanced therapies.
The conclave covered a wide range of themes including India’s innovation pathway, digital transformation, biopharma funding, Manufacturing 4.0, regulatory harmonisation etc.
India's move beyond biosimilars
The day opened with a panel moderated by Dr Dakshesh Mehta, Independent Biopharma Professional. The panelists included Nitin Damle, Executive VP and Chief Innovation Officer, Sun Pharma Advanced Research Company; Sonia Gandhi, DGM & Head (Regulatory Affairs & Policy Advocacy), BIRAC; Dr Mukesh Kumar, Chief Scientific Officer, CLINEXEL; Dr Venkata Ramana, Chief Scientific Officer, Reliance Life Sciences; Dr Vishal Pavitrakar, Sr Director-Global Regulatory Affairs-CMC, Alvotech and Dr Santosh Taur, Director-Medical Affairs, Pfizer.
The session, titled 'From biosimilars to breakthroughs: India's innovation pathway', focused on how India can move up the value chain, from being a manufacturing powerhouse in biosimilars to becoming a true innovation hub for biologics and large molecules.
Denne historien er fra November 2025-utgaven av Express Pharma.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Express Pharma
Express Pharma
Kyasanur Forest Disease - How far is a regulatory approved vaccine?
Dr Priyabrata Pattnaik, Former Deputy MD, Indian Immunologicals, informs about the Kyasanur Forest Disease (KFD), a zoonotic viral hemorrhagic fever endemic to parts of India, particularly along the Western Ghats and discusses the current status of developing a regulatory-approved KFD vaccine in India
3 mins
November 2025
Express Pharma
India's biopharma industry charts the road from biosimilars to innovation
Express Pharma hosted the maiden Biopharma Leadership Conclave 2025 and brought together industry leaders to discuss how India can move from being the world's leading producer of generics and biosimilars to becoming a hub for innovative, affordable, and high-quality biologics and advanced therapies
4 mins
November 2025
Express Pharma
Digital technologies are quietly transforming HVAC into an intelligent compliance partner
Over the last decade, HVAC standards in pharmaceutical manufacturing have undergone a quiet revolution.
2 mins
November 2025
Express Pharma
Direct-to-Retail will increasingly complement traditional pharma distribution
Aqualab has crossed Rs 100 crore in just three years, what have been the key drivers behind this growth, and how does the brand plan to achieve the Rs 250 crore target by FY25-26?Aqualab's journey to Rs 100 crore within three years reflects the strength of a simple yet powerful principle, accessibility through proximity. Our growth has been anchored in three areas: a high-velocity retail network that prioritises last-mile availability, a well-diversified therapeutic portfolio spanning acute and chronic segments, and a strong focus on brand trust built through consistent product quality.
3 mins
November 2025
Express Pharma
Guaranteeing continuity of medicine supply through AI innovation
Hari Kiran Chereddi highlights how AI is transforming pharma supply chains to ensure uninterrupted medicine availability
2 mins
November 2025
Express Pharma
PROSOLV® 730: Directly compressible carrier for lipophilic ingredients
Nearly 90 % of molecules in the discovery pipeline and 40 % of drugs with market approval are poorly water soluble. Poor aqueous solubility can lead to low bioavailability resulting in insufficient plasma levels. Oil-based preparations of these APIs, as well as oily APIs in general, present challenges in terms of solid dosage form manufacturing. PROSOLV® 730 was designed to provide a solution to the formulation of BCS class II and IV APIs. It enables the formulation of lipidic APIs or API-loaded lipid systems by facilitating the adsorption of oil, creating a free-flowing, compactible system that can be further formulated. PROSOLV® 730 is a co-processed, high-functionality excipient comprising MCC SILICA COPOVIDONE
2 mins
November 2025
Express Pharma
Ensuring Clean Room Integrity with Prime Clean Reset High-Speed Doors: Minimizing Air Permeability and Leakages
High-speed doors for clean rooms are specialized industrial doors essential for maintaining controlled environments. These doors are engineered to be airtight, creating a reliable barrier between different areas of a facility. Their design ensures durability and minimal maintenance, reducing the frequency of repairs and replacements.
2 mins
November 2025
Express Pharma
Reimagining cold chain: How IoT secures every pharma mile
Swarup Bose, Co-founder and CEO, Celcius Logistics points out that as the demand for temperature-sensitive medicines surges, maintaining an unbroken cold chain has never been more critical. IoT is emerging as the game-changer that ensures every vial and vaccine arrives potent, safe, and on time
3 mins
November 2025
Express Pharma
Shaping the next gen of global pharmacists: Preparing students for Al, data and precision medicine
Dr Supriya Shidhaye, Principal, Vivekanand Education Society's College of Pharmacy, Mumbai highlights that by modernising curricula, embracing technology, and nurturing globally aware professionals, we can ensure that the next generation of Indian pharmacists leads confidently in a world where medicine, data, and humanity converge
4 mins
November 2025
Express Pharma
HVAC is emerging as a strategic pillar in pharma quality, compliance, and sustainability
Over the past decade, the role of HVAC systems in pharmaceutical manufacturing has evolved from being a utility function to becoming a core enabler of product quality, compliance, and sustainability.
1 mins
November 2025
Listen
Translate
Change font size